Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CD | O00329 | 2/20 | 0.42 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.39 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.38 |
| ▸ | FGFR2 | P21802 | 1/20 | 0.38 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.38 |
| ▸ | FGFR3 | P22607 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 4/20 | 0.36 |
| ▸ | KCNK9 | Q9NPC2 | 4/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 2/20 | 0.34 |
| ▸ | SPR | P35270 | 1/20 | 0.34 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869457 | 1.00 | PIK3CD (0.42) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869591 | 0.94 | PIK3CD (0.41) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869607 | 0.94 | PIK3CD (0.41) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869666 | 0.94 | PIK3CD (0.41) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869774 | 0.87 | PARP1 (0.38) | PARP1FGFR1FGFR2FGFR4FGFR3 | |
| SCHEMBL30869691 | 0.86 | PIK3CD (0.39) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869471 | 0.86 | PIK3CD (0.39) | PIK3CDCHRNA7KCNH2PARP1FGFR1 | |
| SCHEMBL30869646 | 0.84 | CHRNA7 (0.56) | CHRNA7KCNH2FGFR1KDRROCK2 | |
| SCHEMBL30869672 | 0.84 | CHRNA7 (0.56) | CHRNA7KCNH2FGFR1KDRROCK2 | |
| SCHEMBL30869448 | 0.81 | HSD11B1 (0.40) | PARP1FGFR1FGFR2FGFR4FGFR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| EP-4583868-A2 | DYNAMIN ACTIVATORS | Walden Biosciences, Inc. (US) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024054661-A2 | DYNAMIN ACTIVATORS | WALDEN BIOSCIENCES (US) | 2024-03-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260070880-A1 | DYNAMIN ACTIVATORS | DNM1, DNM1L, DNM2 | PIK3CD 127/4885CHRNA7 1850/4885KCNH2 851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.